Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/27/2014EP2768503A1 Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
08/27/2014EP2768502A2 Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
08/27/2014EP2768501A1 Method for treating capillary hemangiomas
08/27/2014EP2768500A2 Treatment of cancer with tor kinase inhibitors
08/27/2014EP2768499A1 Indomethacin analogs for the treatment of castrate-resistant prostate cancer
08/27/2014EP2768498A1 Therapeutic combination for the treatment of cancer
08/27/2014EP2768497A1 Use of aminoacetonitrile derivatives against endoparasites
08/27/2014EP2768496A1 Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
08/27/2014EP2768495A1 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
08/27/2014EP2768494A1 Dosage regimen for an s1p receptor modulator or agonist
08/27/2014EP2768493A1 Phytocannabinoids for use in the treatment of breast cancer
08/27/2014EP2768492A2 Compounds, compositions, and methods for reducing or eliminating bitter taste
08/27/2014EP2768491A1 Inhibitors of arginase and their therapeutic applications
08/27/2014EP2768489A1 Pharmaceutical compositions of resveratrol
08/27/2014EP2768487A1 Sustained-release preparation
08/27/2014EP2768480A1 Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one) -6-yl]-5-fluoro-n2- [3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
08/27/2014EP2768479A1 Excipients for nicotine-containing therapeutic compositions
08/27/2014EP2768478A1 Paste comprising non-steroidal anti-inflammatory
08/27/2014EP2768321A1 Methods and compositions for inducing satiety
08/27/2014EP2768317A1 Methods and compositions for inducing satiety
08/27/2014EP2768316A1 Lipid composition for the prevention or treatment of skin problems
08/27/2014EP2768314A1 Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
08/27/2014EP2768313A1 Composition for use in the promotion of magnesium absorption and/or magnesium retention
08/27/2014EP2768312A1 Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
08/27/2014EP2768311A1 Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
08/27/2014EP2768306A1 Fluorescent dyes
08/26/2014US8816151 Stat5b transgenic mice and methods of use thereof
08/26/2014US8816129 PTP1B inhibitors, synthesis thereof and application thereof in preparation of medicaments for treating type 2 diabetes mellitus
08/26/2014US8816121 GLP-1 receptor stabilizers and modulators
08/26/2014US8816119 Arylamide derivatives having antiandrogenic properties
08/26/2014US8816095 Na channels, disease, and related assays and compositions
08/26/2014US8816092 Indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof
08/26/2014US8816091 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
08/26/2014US8816090 Benzisoxazole derivatives
08/26/2014US8816089 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
08/26/2014US8816087 Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
08/26/2014US8816086 Process for preparing cannabinoid receptor ligands
08/26/2014US8816085 Methylpyrrolopyridinecarboxamides
08/26/2014US8816083 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
08/26/2014US8816082 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
08/26/2014US8816079 Amide derivative and use thereof as medicine
08/26/2014US8816073 Matrix metalloproteinase inhibitors
08/26/2014US8816071 Tocotrienol derivatives and associated methods
08/26/2014US8816070 Triazole derivative as an HSP 90 inhibitor
08/26/2014US8816065 Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof
08/26/2014US8815970 Method of preparing polyurethane
08/26/2014US8815955 Method of treating ocular disorders
08/26/2014US8815954 Arginine heteromers for topical administration
08/26/2014US8815953 Formulations of vitamin K analogs for topical use
08/26/2014US8815952 Chlorhexadine antiseptic
08/26/2014US8815951 Inhibitors of epoxide hydrolases for the treatment of inflammation
08/26/2014US8815950 Pharmaceutical compositions and method of using levodopa and carbidopa
08/26/2014US8815949 Composition for treating influenza a (H1N1) virus and a preparation method therefor
08/26/2014US8815948 High volume and alternative methods of delivering homeopathic remedies
08/26/2014US8815947 Methods of treating metabolic disorders
08/26/2014US8815946 Inhibition of proliferation and fibrotic response of activated corneal stromal cells
08/26/2014US8815945 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
08/26/2014US8815944 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/26/2014US8815942 Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
08/26/2014US8815941 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
08/26/2014US8815940 Coumarin-chalcones as anticancer agents
08/26/2014US8815939 Substituted sulfamide derivatives
08/26/2014US8815938 Double compartment skincare products comprising avermectin/milbemycin compounds
08/26/2014US8815937 Lipoyl compounds and their use for treating ischemic injury
08/26/2014US8815935 Inhibitors of protein prenyltransferases
08/26/2014US8815934 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
08/26/2014US8815933 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
08/26/2014US8815932 Induction of alpha helix conformations in proteins and peptides
08/26/2014US8815931 Oral formulations for tetrapyrrole derivatives
08/26/2014US8815930 Compounds that inhibit TRPV1 and uses thereof
08/26/2014US8815929 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
08/26/2014US8815928 Hepatitis C virus inhibitors
08/26/2014US8815926 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
08/26/2014US8815925 Use of combination preparations comprising antifungal agents
08/26/2014US8815924 Heterocyclic carbonyl compounds
08/26/2014US8815923 Therapeutic compounds
08/26/2014US8815922 Pesticidal compositions and processes related thereto
08/26/2014US8815921 Active substance combination based on trifluorobutinyl compounds and exhibiting nematicidal and insecticidal properties
08/26/2014US8815920 Substituted amide compound
08/26/2014US8815919 Oxadiazole derivatives
08/26/2014US8815918 Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives
08/26/2014US8815917 DP2 antagonist and uses thereof
08/26/2014US8815916 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
08/26/2014US8815915 Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
08/26/2014US8815914 Positive allosteric modulators of nicotinic acetylcholine receptor
08/26/2014US8815912 Wound and mucosa antiseptic based on bispyridiniumalkanes
08/26/2014US8815911 Alfentanil composition for the treatment of acute pain
08/26/2014US8815910 Compounds and methods for inhibiting phosphate transport
08/26/2014US8815909 Diaminocyclohexane compounds and uses thereof
08/26/2014US8815908 Compounds and methods for inhibiting phosphate transport
08/26/2014US8815907 Quaternary ammonium compounds useful as muscarinic receptor antagonists
08/26/2014US8815906 Tyrosine kinase inhibitors
08/26/2014US8815905 Propionic acids, propionic acid esters, and related compounds
08/26/2014US8815903 Indole derivative and pharmacologically acceptable salt thereof
08/26/2014US8815902 Tetrahydroquinoline amide M1 receptor positive allosteric modulators
08/26/2014US8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
08/26/2014US8815900 Compounds and compositions for reducing lipid levels
08/26/2014US8815899 Nutritional activation of telomerase in vitro and in vivo with increased safety
08/26/2014US8815898 6,7-disubstituted-sioquinoline derivatives and their use
08/26/2014US8815897 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof